Figure 1.
Disease-free survival curve for 31 patients with laryngeal-hypopharyngeal squamous cell carcinoma after concurrent chemoradiotherapy with capecitabine/cisplatin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.